Cluster Headache and Other Trigeminal Autonomic Cephalalgias

Area of Science:

• Neurology
• Headache Medicine
• Clinical Neuroscience

Background:

• Trigeminal Autonomic Cephalalgias (TACs) represent a group of primary headache disorders characterized by distinct clinical presentations.
• Accurate differentiation from other headache disorders is essential for effective therapeutic strategies.
• This review synthesizes current knowledge on TACs, including their pathophysiology, epidemiology, diagnosis, and management.

Purpose of the Study:

• To provide a comprehensive overview of the clinical features, differential diagnosis, and management of TACs.
• To highlight recent updates in the classification and treatment of these debilitating headache conditions.

Main Methods:

• Review of current literature on trigeminal autonomic cephalalgias.
• Analysis of recent classification changes and treatment guidelines.
• Synthesis of information on pathophysiology, epidemiology, diagnosis, and management.

Main Results:

• Updated classifications include chronic cluster headache remission periods <3 months and hemicrania continua as a TAC.
• First-line treatments remain consistent: oxygen/triptans/verapamil for cluster headache, indomethacin for paroxysmal hemicrania/hemicrania continua, and lamotrigine for SUNCT/SUNA.
• Neuromodulation offers new therapeutic avenues for refractory cluster headache, emphasizing patient selection.

Conclusions:

• TACs present with overlapping symptoms, necessitating precise diagnosis for optimal treatment.
• Established first-line therapies remain crucial, with emerging neuromodulation techniques offering hope for difficult cases.
• Continued research and clinical vigilance are vital for improving patient outcomes in TACs.